Comment on Why PTC Therapeutics Dropped 30.6% Today After Jumping 27.5% Yesterday

Why PTC Therapeutics Dropped 30.6% Today After Jumping 27.5% Yesterday

In biotech, what goes around comes around.Yesterday, PTC Therapeutics (NASDAQ: PTCT) jumped 27.5% following positive data for its spinal muscular atrophy drug, risdiplam, which sent shares of competitors Biogen and Ionis Pharmaceuticals down on the news.Today, it was PTC Therapeutics' turn to take a hit, falling 30.6% today, after competitor Sarepta Therapeutics (NASDAQ: SRPT) presented data for its gene therapy to treat Duchenne muscular dystrophy (DMD).Continue reading

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News